In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.

Authors :: Ramos EL
Leggat JE
Milford EL
Kirkman RL
Tilney NL
Strom TB
Shapiro ME
Waldmann TA
Carpenter CB
Source :: Transactions of the Association of American Physicians [Trans Assoc Am Physicians] 1989; Vol. 102, pp. 231-9.
Publication Year :: 1989

Subjects :: Cytotoxicity, Immunologic
Graft Rejection
Humans
Immune Tolerance
In Vitro Techniques
Lymphocyte Culture Test, Mixed
Randomized Controlled Trials as Topic
T-Lymphocytes, Regulatory immunology
Antibodies, Monoclonal therapeutic use
Immunosuppression Therapy
Kidney Transplantation immunology
Receptors, Interleukin-2 immunology

Tools